Nobuto yamamoto, director of the division of cancer immunology and molecular biology, socrates institute for therapeutic immunology, philadelphia, pennsylvania, says this is probably the most potent macrophage activating factor ever discovered. Saw an interesting article today regarding something called gc macrophage activating factor gc maf. The maf precursor activity of serum gc protein of prostate cancer patients was lost or reduced because gc protein was deglycosylated by serum alphanacetylgalactosaminidase nagalase secreted from cancerous cells. May 07, 2017 no bodily process, no drug, no treatment could outsmart this diabolical killer. Dose effect analysis revealed that dodecylglycerol ddg, one of the alkylglycerols, stimulates. Nobuto yamamoto, director of the division of cancer immunology and molecular biology, socrates institute for.
Yamamoto division of cancer immunology and molecular immunology, socrates institute for therapeutic immunology, philadelphia, pa 19126, usa 3 division of cancer immunology and. The breast and prostate cancer patients were all cured in less than 6 months of weekly gcmaf injections. I eventually recovered thanks to natural oral immune therapeutics and the pioneering work of dr. Nobuto yamamoto, kazuya hashinaka, masumi ueda, theodore sery, charles benson. Gcmaf is a protein produced by modification of vitamin dbinding protein. Alkylglycerols, inflammation products of lipids in cancerous tissues, are potent macrophage stimulating agents. A defect in the inflammationprimed macrophageactivation cascade in osteopetrotic rats. Nobuto yamamotos research works treatment research. Clinical immunology, volume 119, supplement 1, 2006, page s96.
Yamamoto patented the process of preparing gcmaf by treating. The books homepage helps you explore earths biggest bookstore without ever leaving the comfort of your couch. But since his retirement about 20 years ago he has been the director of something called the socrates institute for therapeutic immunology. May 22, 2008 nobuto yamamoto, hirofumi suyama and hiroyuki yamamoto. Vitamin dbinding protein, the precursor protein for the macrophageactivating factor, is abundant in the serum because gc protein circulates in remarkably high concentration 250350. But when patients are told that a cancer has already spread, a physicians words can hang in the air like a death sentence, leaving behind confusion and despair. The onceweekly injection of minute amounts of gcmaf, just 100 nanograms billionths of a gram, activates macrophages and allows the immune system to pursue cancer cells with vigor, sufficient to produce total longterm cures in humans. Nobuto yamamoto, director of the division of cancer immunology and molecular biology, socrates institute for therapeutic immunology, philadelphia, pennsylvania says this is probably the most potent macrophage activating factor ever discovered. A novel assay system for macrophageactivating factor activity using a human u937 cell line. After graduation he served as associate professor at gifu medical school, japan until 1959. These data could prove useful for upcoming clinical trials on gcmaf. Deglycosylation of serum vitamin d3binding protein by alphan acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus. Only 5% of gc protein carries 25hydroxyvitamin d 3 which is a reservoir.
Nobuto yamamoto discovered gcmaf in 1980 as a professor of microbiology and immunology at hahnemann university school of medicine while carrying out immunological research to understand the mechanism of macrophage activation. Gcmaf treatment for cancer has been agonizingly slow to develop. Download it once and read it on your kindle device, pc, phones or tablets. Volume 5, supplement, pages s1s156 2010 previous volissue. The discovery of the process by which gcmaf is produced was published in 1991 and 1993 by nobuto yamamoto, then a noted immunologist at temple university in philadelphia. How a retired scientists questionable institute convinced. Japan association of cancer immunology, japanese society for immunology, research center for allergy and immunology has decided to promote and interrelate the research and studies practiced in japan in the area of immunology. Nobuto yamamoto, masahiro urade, yoshihiko koga, nobuyuki yamamoto, theodor sery and masumi ueda. Administration of small amounts 10100 ng of alkylglycerols to mice greatly enhanced macrophage activation for fcmediated ingestion activity at the 5th day posttreatment. Serum vitamin d3binding protein gc protein can be converted by. When nobuto yamamoto, phd, first announced the discovery of his cure for stage iv cancer in 2008 i was excited. Nobuto yamamoto, hirofumi suyama and hiroyuki yamamoto.
A trisaccharide composed of nacetylgalactosamine with dibranched. Immunotherapy of metastatic colorectal cancer with vitamin dbinding proteinderived. Thus, gc protein is the precursor of the macrophage activating factor maf. Retraction reasons also included methodological errors in. The launch of many immunology journals has facilitated the clinical and research updates to the readers over the world.
In 2014 the belgian anticancer fund has communicated serious concerns about published studies on gcmaf by yamamoto and colleagues. Nov 04, 2012 the book features 29 projects including the yamakawa villa in nagano, the fujii house in kanagawa, the yamamoto mental clinic in okayama or the saitama prefectural university and includes sketches, blue prints and photos of past and present buildings. Vitamin d binding protein groupspecific component, gc is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine. Structural modification of serum vitamin d3binding. Inflammation induced by bcg in normal tissues releases lysophospholipids that activate macrophages. Mention function of calcitriol hormone in the body. Regulation of immune responses in health and disease kindle edition by yoshimoto, takayuki, yoshimoto, tomohiro. Japanese journal of clinical immunology rg journal impact.
Three out of four of the original studies authored by yamamoto published between 2007 and 2009 were retracted by the scientific journals in which they were published in 2014, officially due to irregularities in the way ethical approval was granted. Nobuto yamamoto was born in japan on april 25, 1925. Gcmaf and nagalase information sheet page 1 of 2 macrophages are beneficial blood cells that kill foreign invaders as part of a regular and proper immune response to foreign bacteria or viruses in the body. Yamamoto was appointed professor of microbiology and immunology at hahnemann university school of medicine, where he continued to study viral evolution and revived his graduate study of immunology from 35 years before. The concept that hiv causes aids only by directly killing cd4 cells has been questioned by a number of investigators. New concepts in aids pathogenesis aids research and. Macrophages play important roles in antitumor immunity, and immunotherapy with the. Nobuyuki yamamotos research works roche institute of. At the research clinic saisei mirai in japan, gcmaf is tested for. Jun 07, 2016 the discovery of the process by which gcmaf is produced was published in 1991 and 1993 by nobuto yamamoto, then a noted immunologist at temple university in philadelphia. Clinical immunology focis 2010 abstract supplement. Published by the japan society for clinical immunology 4,079 registered articles updated on january 20, 2020. Gcmaf and nagalase information sheet karima hirani md. The maf precursor activity of serum gc protein of prostate cancer patients was lost or reduced because gc protein was deglycosylated by serum alphanacetylgalactosaminidase.
Immunotherapy for prostate cancer with gc proteinderived. There has been experimental support for a number of indirect mechanisms such as apoptosis, anergy, superantigeninduced cell proliferation and depletion, defective signaling, molecular mimicry, and autoimmunity. Clinical immunology and immunopathology volume 82, issue 3, march 1997, pages 290298. Detection of activating enzymes for 4nitroquinoline 1. Nobuto yamamoto claims he eradicated hiv using gc proteinderived macrophage activating factor gcmaf. Rivera aa, davydova j, schierer s, wang m, krasnykh v, yamamoto m, curiel dt, nettelbeck dm. For almost 20 years, nobuto yamamoto, director of the division of cancer immunology and molecular biology at socrates institute for therapeutic immunology philadelphia, pennsylvania, has been studying the effect of directly administering gcmaf to cancer patients, thereby bypassing the malignant cells nagalase defense. Immunotherapy of metastatic colorectal cancer with vitamin dbinding proteinderived macrophageactivating factor, gcmaf. Nagalase testing finds cancer cells early and gcmaf cures it naturalhealth365 any cancer diagnosis can be terrifying. The colorectal cancer study took about a year to cure all subjects. Nagalase testing finds cancer cells early and gcmaf cures. Yamamoto comes from a prestigious background having been appointed a full professor of microbiology and immunology at hahnemann university school of medicine. Abstract serum gc protein known as vitamin d3binding protein is the precursor for the principal macrophage activating factor maf. Fastforward a few years, to the publication of three papers detailing the results of clinical trials of gcmaf carried out by yamamoto, testing the treatment on patients with breast, bowel and prostate cancer.
Gcmaf should be distinguished from tcell lymphokine macrophage activating factor, also known as. Suyama nagasaki immunotherapy research group, yokoh, nagasaki, japan 2 n. Yamamoto was a biology researcher in philadelphia for many years. Usually, with most breast cancer patients 4 to 6 months is necessary to fully activate the immunity. These results imply that salmonella typhimurium is able to convert 4nqo to 4haqo and that 4haqo reacts with the genomes. Orlando, fl intratumor bcg administration eradicates local as well as metastasized tumors e. When nobuto yamamoto, phd, first announced the discovery of his cure. Shifting the medical paradigm with gcmaf and raw milk. Volume 127, supplement, pages s1s178 2008 previous volissue. Remarkably, yamamoto accomplished these cures relatively rapidly. Gcmaf has not been properly studied in clinical trials and its.
The breast cancer paper yamamoto et al int j cancer 2008 has now been retracted, due to various concerns with. Globulin component macrophage activating factor gcmaf. Decreased nagalase activity was associated with improved clinical conditions and no adverse side effects were reported. Vitamin dbinding protein an overview sciencedirect topics. Nobuto yamamoto 0 1 2 4 hirofumi suyama 0 1 2 4 0 h. Here youll find current best sellers in books, new releases in books, deals in books, kindle ebooks, audible audiobooks, and so much more. The integrity of the research, conducted by nobuto yamamoto and colleagues, that. Yamamoto, nobuto, naofumi ushijima, and yoshihiko koga. Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of car. Nakazato yokoyama gastroenterology hospital, nagoya, japan 1 h.
Nobuto yamamoto, in encyclopedia of immunology second edition, 1998 effect of calcitriol in vitro on lymphocytes calcitriol has also been shown to act on t and b lymphocytes, and antibody. Published by the japan society for clinical immunology 4,079 registered articles updated on december 27, 2018. Gc macrophage activating factor gcmaf cancer magic. These macrophages are activated by a protein called gcmaf gcmacrophage activating factor.
Calcitriol has also been shown to act on t and b lymphocytes, and antibodyproducing function of lymphocytes table 1. The maf precursor activity of serum gc protein of prostate cancer patients was lost or reduced because gc protein was deglycosylated by serum alphan. Gcmaf immunotherapy bioregulatory medicine institute. Cancer immunotherapy with macrophage activating factor.
Chief, journal of medical virology and wiley periodicals, inc. Best practices research clinical endocrinology metabolism oct 2015 true, there are inconsistencies in the initial gcmaf research published by nobuto yamamoto. Cancer cure the two c words we are never to utter cancer. Conditionally replicative adenovirus for gastrointestinal cancers. Yamamoto, who holds a phd in biochemistry from gifu university in japan, has been a usbased researcher since 1959, when he was invited to be a visiting associate researcher at the fox chase cancer center in philadelphia. Nobuto yamamoto, masumi ueda, kazuya hashinaka, theodore sery, charles benson. Is there a name and contact number for a person organizing the clinical trial in the bahamas. Revolutionary suppressed treatment, gcmaf, has the potential to reverse cancer, autism, hiv, liverkidney disease and diabetes as well as promote proper immunity function. Research latest cancer research secrets members members. Shifting the medical paradigm with gcmaf and raw milk the. Macrophageactivating factor an overview sciencedirect topics. This book offers the information essential for gaining a full understanding of the principles and use of ynsa based on specific algorithms for diagnosis and treatment. Nobuto yamamotos 23 research works with 246 citations and 2,245 reads, including. Nobuto yamamoto claims he eradicated hiv using gcmaf, a.
Macrophages activated by gcmaf develop enormous variation of receptors that recognize and eradicate adenocarcinomas. Homma s, yamamoto m, yamamoto n 1993 vitamin d binding protein groupspecific component, gc is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine. Clinical immunology vol 155, issue 2, pages 149238. Since my recovery i have sought to make their research known to the general public. When phage p22 is treated with 4haqo and assayed on s.
He spent a quarter of a century examiningin minute detailthe basic molecular biology and immunology supporting his discoveries, alphanacetylgalactosaminidase nagalase and glycoprotein macrophage activating factor gcmaf. Japan immunology journals list omics publishing group. In the pretest for merely realisation stage koma offering occurred in only 5% of trials apart from one individual, all chimpanzees first offered tools stick or straw on significantly more occasions than none 2 objects. Sep 05, 2017 how a retired scientists questionable institute convinced the internet that cancer was cured. Sure, highpowered drugs and radiation will take out many of the cancer cells and in some cases produce a cure, but until dr. Inflammationderived macrophage activation is the principal macrophage activation process that requires serum vitamin dbinding protein known as gc protein and participation of b and t lymphocytes. Macrophage activating factor an overview sciencedirect topics.
Shorts by klotter augsept 2010 townsend letter for doctors. Yamamoto new scalp acupuncture ynsa is a microsystem of anatomical scalp acupoint treatment for neuromusculoskeletal pain as well as meridian treatment. Yamamoto became a biochemistry research professor at temple university medical school, where he studied. Immunotherapy of chronic lymphocytic leukemia patients. Clinical immunology focis 2008 abstract supplement 8th. Eradication of prostate cancer by immunotherapy using the. Diagnosis cancer, what is cancer, what causes cancer.
A reduction product of 4nqo, 4hydroxyaminoquinoline 1oxide 4haqo, damages both the bacterial and phage genomes. Immunotherapy of hivinfected patients with gc proteinderived macrophage activating factor gcmaf abstract serum gc protein known as vitamin d3binding protein is the precursor for the principal macrophage activating factor maf. Yamamoto discovered the macrophage activating factor gcmaf and published three clinical trials showing remarkable results for cancer. His immunological studies emphasized mechanism of macrophage activation and discovered gcmaf. I have written previous articles observing heavy metals and more specifically mercurys role in the onset of autism spectrum disorders, but another huge factor is at play too. Jul 05, 2016 when nobuto yamamoto, phd, first announced the discovery of his cure for stage iv cancer in 2008 i was excited. Cancer immunology, immunotherapy volume 57, number 7 july 2008 published in an early online edition of this journal, this confirming report has received no attention by the new media so far, despite its striking importance. Though accepted to three medical schools, he chose to focus on biochemistry in graduate school. The portal can access those files and use them to remember the users data, such as their chosen settings screen view, interface language, etc. Professor nobuto yamamoto didand still doesbasic science research. Macrophage activating factor an overview sciencedirect.
95 1140 31 59 989 890 850 1291 599 543 242 337 1105 542 583 532 627 1444 237 1482 431 1207 1463 1428 483 1393 507 682 1255 1161 1274 527 1206 1138 1224 1369 370 1420 124 491 996 1464